Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts

• Main Authors: Sorawit Chittrakarn (Author), Pisud Siripaitoon (Author), Sarunyou Chusri (Author), Siripen Kanchanasuwan (Author), Boonsri Charoenmak (Author), Thanaporn Hortiwakul (Author), Phaiwon Kantikit (Author), Narongdet Kositpantawong (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTThe immune response to heterologous coronavirus disease (COVID-19) vaccination in people living with HIV (PLWH) is still unclear. Herein, our prospective cohort study aimed to compare the immune response of heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) between...